The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
Annual MeetingFull Access

Doping and Athletics

Given the big stakes in scholastic and professional athletics, it's not surprising that athletes succumb to the temptation or pressure to take performance-enhancing drugs. And sometimes athletes need to take substances that are banned for medical reasons. These are just some of the issues and problems that will be discussed in the symposium “Doping and the Athlete” at APA's 2010 annual meeting.

The symposium, which will be held Saturday, May 22, at 1 p.m., will be led by Antonia Baum, M.D. Topics include the history of doping in athletics and the anti-doping movement, a guide to the therapeutic-use exemption for psychiatrists treating athletes with medications on the banned-substance list and how to make the case to get such an exemption, the role of the U.S. Anti-Doping Agency in the therapeutic-exemption process, doping-control efforts in collegiate athletics from the NCAA perspective, and the ethics of doping in athletics. Questions will be taken from the audience at the end of the session.